Epigenetic Reprogramming Potentiates ICAM1 Antibody Drug Conjugates in Preclinical Models of Melanoma
Abstract
Research context
OpenAlex topics: CAR-T cell therapy research · Protein Degradation and Inhibitors · Cancer Immunotherapy and Biomarkers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Medical Oncology Zhejiang Provincial People's Hospital Hangzhou Zhejiang 310022 China
Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou Zhejiang 310014 China
Hangzhou Institute of Medicine (HIM) Chinese Academy of Sciences Hangzhou Zhejiang 310022 China
Department of Radiation Oncology The Cancer Hospital of the University of Chinese Academy of Sciences Zhejiang Cancer Hospital Hangzhou Zhejiang 310022 China
Key Laboratory of Head and Neck Cancer Translational Research of Zhejiang Province Zhejiang Cancer Hospital Hangzhou Zhejiang 310022 China
Department of Head and Neck Surgery The Cancer Hospital of the University of Chinese Academy of Sciences Zhejiang Cancer Hospital Hangzhou Zhejiang 310022 China
MabPlex International Yantai Shandong 264006 China
Department of Pathology The Cancer Hospital of the University of Chinese Academy of Sciences Zhejiang Cancer Hospital Hangzhou Zhejiang 310022 China
Department of Gastroenterology and Metabolism Nagoya City University Graduate School of Medical Sciences Nagoya 467–8601 Japan
School of Materials Science and Engineering Tianjin University Tianjin 300072 China
Department of Urology Children's Hospital of Chongqing Medical University Chongqing China
Funding
National Key Research and Development Program of China · National Natural Science Foundation of China · Medical Science and Technology Project of Zhejiang Province · Science Fund for Distinguished Young Scholars of Zhejiang Province · Natural Science Foundation of Zhejiang Province